2nd KEMRI Annual Scientific & Health Conference (KASH)

In order to view this object you need Flash Player 9+ support!

Get Adobe Flash player

Powered by RS Web Solutions

Thursday, August 25, 2016
Text Size
   

Tenders

Invitation to Tender

Press Statement

KEMRI Press Statement-page

Job Opportunities

Vacancies KEMRI

In the News

mainstreaming-gender-matters-at-the-institute The newly appointed Institute’s Gender Mainstreaming Committee hit the road running with a resolution to formulate a new Work Place Gender-based...
beyond-zero-campaign Members of the KEMRI team that participated in the 10KM First Lady Half Marathon 2016 in aid of the Beyond Zero Campaign.
kemri-destroys-its-stockpiles-of-polio-viruses-The Kenya Medical Research Institute (KEMRI) undertook the destruction of stockpiles of circulating vaccine derived polioviruses type 2 in a historic...
eu-funds-kemris-tb-researchThe Institute will lobby for more funding to support the activities of the Malaria Diagnostic Centre (MDC) in Kisumu to boost its capacity as a regional...
switzerland-seeks-more-collaboration-with-kemri-scientists- Ambassador, Mauro Moruzzi, the head of International Affairs at the Swiss State Secretariat for Education, Research and Innovation is briefed by the...

Calendar of Events

August 2016 September 2016
Su Mo Tu We Th Fr Sa
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31
There are no upcoming events to display
View Full Calendar

Newsletters

KEMRI Bioethics Review Vol VI  Iissue II 2016-page-001

 

KEMRI Bioethics Review Vol 6 Issue 1_Page_01

 

 

kemri buleting doc issue 6 final.pdf low version final_Page_01

 

 

KEMRI Bioethics Revew Issue 4 2015

 

downloadsubscribe


 

 

 

 

 

 

      

NIH pay courtesy Call to KEMRI

NIH

Acting Director, KEMRI Dr. Gerald Mkoji poses for a group photograph with Dr. Francis Collins, the Director, National Institute of Health (NIH when he paid him a courtesy call at KEMRI Headquarters. Also present were KEMRI Board Members, Mr. Lazarus Tonui, Dr. Moses Alobo, Dr. (Amb). Wenwa Odinga and Director, CDC-Kenya, Dr. Kevin De Cock. Dr. Collins was accompanied by other NIH members Dr. Stency Wallick, Dr. Rogers Glass among others while Ag. Director KEMRI accompanied by his Deputy Director (R&D) Dr. Evans Amukoye, Corporation Secretary & Head of Legal, Eunice Kitche, Chief Finance Officer (Grants), Geireth Kingi and the Head, Grantsmanship Office Dr. Luna Kamau. The purpose of the visit was to discuss possible collaboration between KEMRI and NIH. After the courtesy call Dr. Collins briefly addressed NIH Grantees at the KEMRI Headquarters Conference Hall before being conducted on a tour of various KEMRI Laboratories.

KENYA MEDICAL RESEARCH INSTITUTE (KEMRI)
2nd KEMRI Annual Scientific & Health Conference (KASH)

Theme: Towards A Healthy, Globally Competitive Nation: Vision 2030 Flagships

Dr. Edwin Muinga

Dr. Edwin Muinga Chokwe, HSC,
Chairman, KEMRI Board of Management

Attaining Kenya Vision 2030, the nation's economic blueprint, requires a fresh perspective in the way we perceive research and KEMRI's role in national development. The link between health and poverty is self evident as each impacts the other resulting in a vicious cycle where poor health is both a result and a cause of poverty.

As such the dealing with one without being cognizant of the other only serves to derail the desired impact. Health research should therefore be linked to economic development through the promoting of human and social development, and also more directly through industrialization as we strive to attain a knowledge-economy driven, middle income status by the year 2030. This was reflected in the theme of this year's conference, "Towards a healthy, globally competitive nation: Vision 2030 flagships," which affirms KEMRI's role not just in human and social development but also in the knowledge economy through the innovation of R&D outputs.

 

Bridging the Gap in Health Research in Africa

This conference therefore serves to showcase excellence in research as the bedrock of this theme. Two major ground breaking research results emanating from research carried out by KEMRI and our collaborators have recently been listed among the top 10 technological breakthroughs of the year by the journal Science. This includes the phase III clinical trial results of the candidate malaria vaccine RTSS, which reported 56 percent and 47 percent efficacy in the prevention of clinical and severe malaria in children respectively. The multicentre trial was conducted in 11 sites across 7 African countries, in which KEMRI played a significant role, having hosted 3 of the 11 sites at the KEMRI/CDC Research and Public Health Collaboration in Kisumu, the KEMRI-Wellcome-Trust Research Programme in Kilifi and the KEMRI/Walter Reed Project site at Kombewa.

The other major breakthrough in which KEMRI has been involved is the HIV Prevention Trials Network (HPTN) multinational clinical study, HPTN 052, which demonstrated reduction of HIV transmission in serodiscordant couples through the early treatment of HIV using ARVs by an astounding 96 percent. Both studies have served to inform policy and revitalize the fight against the scourge of these diseases not just in Kenya but the world over.

Additionally, KEMRI remains committed to the national and WHO roadmaps for the control and elimination of 10 of the 17 neglected tropical diseases by the year 2020. Significant advances have been made on this front with results emanating from DNDi, of which KEMRI is both a founding member and partner through CCR, have informed the WHO recommendation of paramomycin-sodium

 stibogluconate (PM-SSG) drug combination as the first line treatment for visceral leishmaniasis in east Africa.

Further to the excellent research coming out of KEMRI, the conference also highlighted special areas of public health interest through dedicated symposia focusing on road safety, neglected tropical diseases, bioethics, health systems and social sciences research, all addressing aspects of health and human/social development.

For the first time, a symposium on pharmaceutical and health products innovation, focusing solely on the business of the science addressed aspects of knowledge economy and industrialization.

DKDr. Solomon Mpoke, PhD, MBS,
Director, KEMRI

 

Health and Interior & Coordination of National Government Cabinet Secretaries Day at KEMRI

Boardroom

This is my point: Ministry of Interior and Coordination of National Government, Cabinet Secretary Hon. Joseph Nkaissery (right) stresses a point as his Ministry of Health colleague, Dr. Cleopa Mailu (centre) and Acting Director KEMRI, Dr. Gerald Mkoji listen. This was during a visit in KEMRI on 15th April 2016 to assess the security situation at the Institute.

Press statement

This is my point: Cabinet Secretary of Health Dr. Cleopa Mailu addressing the press as his Interior and Coordination of National Government colleague, Hon. Joseph Nkaissery (center) and Acting Director KEMRI, Dr. Gerald Mkoji (immediate left) and other senior officials from the two ministries and Institute staff listen. This was during a visit in KEMRI on 15th April 2016 to assess the security situation at the Institute.

US National Cancer Institute Centre for Global Health Experts Visits KEMRI

US CANCER VISIT

Acting Director, KEMRI Dr. Gerald Mkoji poses for a group photograph with Ms. Kalina Duncan from the US National Cancer Institute Centre for Global Health (US NCI,CGH) when she paid a courtesy call on him at KEMRI Headquarters. In the picture from left is Dr. Leah Kirumbi, Acting Director Centre for Clinical Research, KEMRI, Ms. Mishka Cira, Kenya Country Consultant, US NCI,CGH , Ms. Anne Korir, Head Cancer Registry Unit at KEMRI and Mr. Nathan Brand, Ms. Hillary Topazian, Ms. Camille Morgan, all from the US National Cancer Institute Centre for Global Health.

The purpose of the visit was to discuss possible collaboration between KEMRI and the US NCI,CGH that will strengthen the Cancer Registries in Kenya. The visit was a follow-up to the 2014 National Cancer Stakeholders Meeting.

We have 1443 guests online

Vision

"To be a leading centre of excellence in research for human health."

Mission

"To improve human health and quality of life through research, capacity building, innovation and service delivery."

                                                                                                                                                                                                                                           iso90012008

                                                                                                                                             

Motto

"In Search of Better Health"
towards the realization of our Vision

 

 

KEMRI ISO 9001:2008 CERTIFIED

Complaints

Do you have a complaint?
Click Here